comparemela.com

Latest Breaking News On - Onclive tv - Page 13 : comparemela.com

Dr Auletta on the Impact of Post-Transplant Cyclophosphamide in Hematologic Malignancies

Jeffery Auletta, MD, discusses the impact of post-transplant cyclophosphamide in hematologic malignancies.

Jeffery aulettaOhio state university college of medicineOhio state universityOhio state university comprehensive cancer centerLeukemia research programInfectious diseasesNationwide childrenOhio state university collegeRegenerative medicineCell based therapiesTransplantation and cellular therapy meetingsOnclive tv

Dr Gomez Arteaga on an Investigation of Orca-T Vs PTCy-Based HCT in Acute Leukemia and MDS

Alexandra Gomez Arteaga, MD, discusses a retrospective study of Orca-T vs post-transplant cyclophosphamide in acute leukemia and MDS.

Alexandra gomez arteagaDivision of hematologyMedical oncologyWeill cornellNew york presbyterian hospitalCellular therapyTransplantation and cellular therapy meetingsOnclive tvPost transplant cyclophosphamideAcute leukemia

Dr Lee on 3-Year Follow-Up Data From the ROCKstar Trial of Belumosudil in cGVHD

Stephanie Lee, MD, MPH, discusses 3-year follow-up data from the phase 3 ROCKstar Study of belumosudil in cGVHD.

Stephanie leePatricia giuliani oliver pressFred hutchinson cancer centerCancer researchClinical research divisionOliver press endowed chairCellular therapy meetingsTransplantation and cellular therapy meetingsOnclive tv

Dr Bertaina on T-allo10 Infusion in Young Patients With Hematologic Malignancies

Alice Bertaina MD, PhD, discusses T-allo10 infusion post–aβdepleted-HSCT in young patients with hematologic malignancies.

Alice bertainaDivision of pediatric hematologyBass centerStanford universityInpatient servicesChildhood cancerBlood diseaesesStem cell transplantRegenerative medicineLucile packard childrenCell transplantationPediatric hematologyStem cell transplantationStanford medicineTransplantation and cellular therapy meetingsOnclive tv

Dr Jagsi on the Feasibility of Radiation Omission Following Surgery in Breast Cancer Care

Reshma Jagsi, MD, DPhil, discusses 5-year findings from the IDEA trial assessing radiotherapy omission for postmenopausal patients with breast cancer.

Lawrencew davisReshma jagsiDepartment of radiation oncologyEmory university school of medicineRadiation oncologyEmory university schoolWinship cancer institute of emory universityOnclive tvBreast cancerEndocrine therapy

vimarsana © 2020. All Rights Reserved.